Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 4 studies | 37% ± 19% | |
ciliated cell | 3 studies | 21% ± 3% | |
macrophage | 3 studies | 16% ± 1% | |
dendritic cell | 3 studies | 24% ± 6% |
Insufficient scRNA-seq data for expression of ARMT1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 901.44 | 1445 / 1445 | 100% | 27.19 | 183 / 183 |
lung | 99% | 1298.81 | 574 / 578 | 100% | 35.26 | 1154 / 1155 |
breast | 100% | 1302.33 | 459 / 459 | 99% | 169.75 | 1108 / 1118 |
brain | 100% | 958.86 | 2631 / 2642 | 99% | 20.15 | 699 / 705 |
thymus | 100% | 1606.14 | 653 / 653 | 98% | 46.80 | 593 / 605 |
stomach | 100% | 745.97 | 358 / 359 | 98% | 30.24 | 281 / 286 |
uterus | 100% | 1065.88 | 170 / 170 | 98% | 34.19 | 449 / 459 |
ovary | 100% | 1296.06 | 180 / 180 | 97% | 27.89 | 419 / 430 |
intestine | 100% | 1057.63 | 966 / 966 | 97% | 31.09 | 511 / 527 |
bladder | 100% | 1012.00 | 21 / 21 | 97% | 28.39 | 488 / 504 |
kidney | 100% | 1454.07 | 89 / 89 | 96% | 39.51 | 868 / 901 |
liver | 100% | 1193.19 | 226 / 226 | 96% | 26.47 | 388 / 406 |
prostate | 100% | 804.09 | 244 / 245 | 95% | 20.78 | 479 / 502 |
pancreas | 95% | 407.15 | 313 / 328 | 97% | 23.12 | 173 / 178 |
skin | 99% | 1023.53 | 1789 / 1809 | 89% | 26.50 | 422 / 472 |
adrenal gland | 100% | 1391.81 | 258 / 258 | 87% | 20.63 | 201 / 230 |
adipose | 100% | 1173.33 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 998.86 | 241 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1015.62 | 1334 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 855.41 | 802 / 803 | 0% | 0 | 0 / 0 |
heart | 97% | 786.39 | 837 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 93% | 27.39 | 42 / 45 |
lymph node | 0% | 0 | 0 / 0 | 93% | 33.15 | 27 / 29 |
peripheral blood | 79% | 891.53 | 731 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 61% | 11.04 | 49 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006974 | Biological process | DNA damage response |
GO_0032259 | Biological process | methylation |
GO_0016791 | Molecular function | phosphatase activity |
GO_0019899 | Molecular function | enzyme binding |
GO_0097023 | Molecular function | fructose 6-phosphate aldolase activity |
GO_0008983 | Molecular function | protein-glutamate O-methyltransferase activity |
GO_0005515 | Molecular function | protein binding |
GO_0051998 | Molecular function | protein carboxyl O-methyltransferase activity |
GO_0008757 | Molecular function | S-adenosylmethionine-dependent methyltransferase activity |
GO_0046872 | Molecular function | metal ion binding |
GO_0103026 | Molecular function | fructose-1-phosphatase activity |
Gene name | ARMT1 |
Protein name | Sugar phosphate phosphatase (EC 2.1.1.-) (EC 3.1.3.-) Damage-control phosphatase ARMT1 (EC 3.1.3.-) (Acidic residue methyltransferase 1) (Protein-glutamate O-methyltransferase) (EC 2.1.1.-) (Sugar phosphate phosphatase ARMT1) Acidic residue methyltransferase 1 |
Synonyms | C6orf211 |
Description | FUNCTION: Metal-dependent phosphatase that shows phosphatase activity against several substrates, including fructose-1-phosphate and fructose-6-phosphate (By similarity). Its preference for fructose-1-phosphate, a strong glycating agent that causes DNA damage rather than a canonical yeast metabolite, suggests a damage-control function in hexose phosphate metabolism (By similarity). Has also been shown to have O-methyltransferase activity that methylates glutamate residues of target proteins to form gamma-glutamyl methyl ester residues . Possibly methylates PCNA, suggesting it is involved in the DNA damage response . . FUNCTION: Metal-dependent phosphatase that shows phosphatase activity against several substrates, including fructose-1-phosphate and fructose-6-phosphate. Its preference for fructose-1-phosphate, a strong glycating agent that causes DNA damage rather than a canonical yeast metabolite, suggests a damage-control function in hexose phosphate metabolism. Has also been shown to have O-methyltransferase activity that methylates glutamate residues of target proteins to form gamma-glutamyl methyl ester residues. Possibly methylates PCNA, suggesting it is involved in the DNA damage response. . |
Accessions | ENST00000367294.4 F5GZY1 Q9H993 ENST00000494826.1 ENST00000545879.5 F2Z3I8 |